Protara Therapeutics, Inc. (TARA)
2.53
+0.09
(+3.69%)
USD |
NASDAQ |
Nov 13, 16:00
2.525
0.00 (0.00%)
After-Hours: 19:59
Protara Therapeutics Price : 2.53 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 2.49 | 2.58 | 2.37 | 2.53 | 728221.0 |
| Nov 12, 2026 | 2.61 | 2.64 | 2.385 | 2.44 | 1.135M |
| Nov 11, 2026 | 2.43 | 2.70 | 2.40 | 2.62 | 766179.0 |
| Nov 10, 2026 | 2.49 | 2.51 | 2.33 | 2.43 | 460646.0 |
| Nov 09, 2026 | 2.29 | 2.56 | 2.26 | 2.51 | 915047.0 |
| Nov 06, 2026 | 2.12 | 2.34 | 2.09 | 2.30 | 690546.0 |
| Nov 05, 2026 | 2.34 | 2.46 | 2.11 | 2.13 | 627777.0 |
| Nov 04, 2026 | 2.385 | 2.54 | 2.34 | 2.35 | 352383.0 |
| Nov 03, 2026 | 2.41 | 2.535 | 2.37 | 2.41 | 481491.0 |
| Nov 02, 2026 | 2.50 | 2.52 | 2.38 | 2.41 | 588572.0 |
| Oct 30, 2026 | 2.51 | 2.57 | 2.43 | 2.48 | 581162.0 |
| Oct 29, 2026 | 2.52 | 2.625 | 2.50 | 2.52 | 553342.0 |
| Oct 28, 2026 | 2.45 | 2.515 | 2.365 | 2.49 | 1.207M |
| Oct 27, 2026 | 2.33 | 2.48 | 2.31 | 2.47 | 1.843M |
| Oct 26, 2026 | 2.35 | 2.43 | 2.305 | 2.35 | 892648.0 |
| Oct 23, 2026 | 2.39 | 2.47 | 2.28 | 2.33 | 867582.0 |
| Oct 22, 2026 | 2.47 | 2.525 | 2.42 | 2.44 | 1.762M |
| Oct 21, 2026 | 2.57 | 2.61 | 2.49 | 2.50 | 971159.0 |
| Oct 20, 2026 | 2.34 | 2.575 | 2.33 | 2.56 | 1.501M |
| Oct 19, 2026 | 2.35 | 2.43 | 2.295 | 2.33 | 1.178M |
| Oct 16, 2026 | 2.38 | 2.465 | 2.32 | 2.32 | 1.165M |
| Oct 15, 2026 | 2.51 | 2.558 | 2.375 | 2.40 | 861832.0 |
| Oct 14, 2026 | 2.60 | 2.659 | 2.47 | 2.48 | 705524.0 |
| Oct 13, 2026 | 2.77 | 2.83 | 2.615 | 2.62 | 930392.0 |
| Oct 12, 2026 | 2.75 | 2.79 | 2.705 | 2.77 | 1.081M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0078 |
| Brainstorm Cell Therapeutics, Inc. | 0.99 |
| Summit Therapeutics, Inc. | 14.15 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 3.92 |
Price Related Metrics
| Price to Book Value | 1.076 |
| Earnings Yield | -54.75% |
| Market Cap | 151.72M |